Psyence Biomedical is a life science biotechnology company that focuses on advancement of psychedelic medicines.
Psyence Biomedical has raised $1.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.
Psyence Biomedical's investors include WHITE LION CAPITAL.
Psyence Biomedical is headquartered in Toronto, Canada.
Psyence Biomedical is a life science biotechnology company that focuses on advancement of psychedelic medicines.
Psyence Biomedical is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Psyence Biomedical — Funding & Investors." VCBacked, December 23, 2024, https://www.vcbacked.co/company/psyence-biomedical. Accessed August 17, 2026.
VCBacked. (2024). Psyence Biomedical — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/psyence-biomedical
{{cite web |title=Psyence Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/psyence-biomedical |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated